Apple Group(SH:603020) Shang Hai Zheng Quan Bao·2026-02-05 18:10Core Viewpoint - The company, Aipu Flavor Group Co., Ltd., has signed a Letter of Intent for Equity Acquisition with NovoSana (Europe) B.V. to acquire 100% equity of NovoSana (Taicang) Biotechnology Co., Ltd., with an estimated value of no less than RMB 450 million [3][11]. Group 1: Basic Information of the Agreement - The agreement aims to enhance the company's strategic layout and promote the extension of the industrial chain for high-quality development [5]. - The initial transaction involves the acquisition of 80% equity, with a second transaction planned after the performance commitment period [10][11]. - The estimated value of the target company's 100% equity is set at no less than RMB 450 million, with the final price to be determined through due diligence and negotiation [3][11]. Group 2: Financial and Operational Details - The target company, NovoSana (Taicang) Biotechnology Co., Ltd., specializes in the research, production, and sales of Omega-3 raw materials, including fish oil and algae oil [7]. - The target company has accumulated significant industry resources and has a client base that includes globally recognized health products and functional food companies [7]. - The financial status of the target company includes an estimated audited net profit of RMB 38 million for 2025 and total equity of RMB 148.64 million [12]. Group 3: Transaction Conditions and Obligations - The agreement stipulates that the buyer will pay a deposit of RMB 10 million within five working days after signing the Letter of Intent [15]. - The funding for the acquisition will come from the company's own or self-raised funds, ensuring no impact on normal operations [22]. - The agreement includes exclusivity clauses preventing the seller from engaging with third parties regarding the sale of the target company's equity until the transaction is completed [17].